Neil Harris Cohen Chemomab Therapeutics Ltd. (CMMB) insider trading activity

CMMB Quotes by TradingView

Neil Harris Cohen is Director of Chemomab Therapeutics Ltd.. Currently has a direct ownership of 10,000 shares of CMMB, which is worth approximately $18,200. The most recent transaction as insider was on Nov 16, 2022, when has been sold 2,409 shares (American Depositary Shares) at a price of $2.0 per share, resulting in proceeds of $4,818. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
0% 12M change
Total Value Held $18,200

Neil Harris Cohen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2022
SELL
Open market or private sale
$4,818 $2.0 p/Share
2,409 Reduced 19.41%
10,000 American Depositary Sh...
May 18 2022
BUY
Open market or private purchase
$6,380 $3.19 p/Share
2,000 Added 13.88%
12,409 American Depositary Sh...
Mar 14 2022
BUY
Open market or private purchase
$26,100 $4.35 p/Share
6,000 Added 36.57%
10,409 American Depositary Sh...
Dec 06 2021
BUY
Open market or private purchase
$14,860 $7.43 p/Share
2,000 Added 31.21%
4,409 American Depositary Sh...
Mar 16 2021
BUY
Open market or private purchase
$99,998 $41.51 p/Share
2,409 Added 50.0%
2,409 American Depositary Sh...
NHC

Neil Harris Cohen

Director
Cambridge, MA

Track Institutional and Insider Activities on CMMB

Follow Chemomab Therapeutics Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CMMB shares.

Notify only if

Insider Trading

Get notified when an Chemomab Therapeutics Ltd. insider buys or sells CMMB shares.

Notify only if

News

Receive news related to Chemomab Therapeutics Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CMMB